Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?

If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:

Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Prempro Lawsuits Result in Big Punitive Damages for Pfizer

Nov 24, 2009 | Parker Waichman LLP Pfizer Inc. has been ordered to pay punitive damages totaling $103 million in two lawsuits involving Prempro.  Prempro is a hormone replacement therapy medication marked by Pfizer's Wyeth unit.

A Philadelphia jury yesterday awarded $28 million in punitive damages to a 66-year-old woman who claimed her breast cancer was the result of taking Prempro and Provera, another hormone medication made by Pfizer's Upjohn unit.  As we reported yesterday, the plaintiff had a double mastectomy in 2002 after taking the hormone-replacement drugs for 11 years. The verdict, which was handed down on Friday, also included $6.3 million in compensatory damages.  It was the largest compensatory damage award  in cases tried in Philadelphia so far.

Jurors concluded that Wyeth and Upjohn officials failed to adequately warn the plaintiff's doctors about the drugs’ cancer risks and that failure played a role in the physicians’ decision to prescribe Prempro and Provera. They also found that Wyeth’s and Upjohn’s conduct in marketing and selling the drugs was “wanton and reckless,” leaving the companies subject to a punitive damage award.

According to the Philadelphia Inquirer, the second punitive damage award involved a case that was decided earlier.  The verdict, which was unsealed yesterday, awarded that plaintiff $75 million in punitive damages.  The plaintiff had also been awarded $3.5 million in compensatory damages.  However, according to the Inquirer, the punitive award will likely be reduced because it exceeds the compensatory damages by such a large margin.

Hormone therapy drugs like Premarin, Prempro, Premphase and Provera are used to treat the hot flashes and other symptoms that accompany menopause  In 2002, a major study conducted by the National Institutes of Health (NIH) determined that Prempro, Premarin and similar drugs significantly increased the risk of stroke, blood clots, heart attacks and breast cancer. The  results were so alarming that the NIH canceled the study, citing risk to the study’s participants. The authors of the study suggested that many of the women who used the medications should quit and talk to their doctors about alternatives.

The 2002 findings resulted in a deluge of lawsuits against the makers of hormone therapy drugs.  According to the Inquirer, Pfizer faces about 10,000 similar suits around the country.

A legal expert told the Inquirer that the punitive damage awards in the Philadelphia Prempro lawsuits could indicate that "jurors are sending a message that they are angry about the corporate conduct in the cases."

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo